ADMA Biologics (ADMA) Soars 11.6% as Firm Denies Short Seller Allegations.
Share this article
Corporate
Score 65
Bullish
ADMA Biologics (ADMA) Soars 11.6% as Firm Denies Short Seller Allegations
Mar 28, 2026 04:27 UTC
ADMA, XLV, IAT
Short term
Related Articles
Score 72
Leadership Conflict at Philippine Conglomerate Sparks Concern Over ABS-CBN Capital Move
Mar 29, 06:01
Score 65
Bullish
Telefonica AGM OKs All Board Proposals, Confirms €0.15 Dividend and Transformation Strategy
Mar 28, 23:02
Score 65
Bullish
SpaceX And Anthropic IPO Frenzy Begins Early As REX Shares, Tuttle Capital File For 2x Leveraged ETFs
Mar 28, 22:31
Score 78
Bearish
Oracle stock dividend under threat amid massive AI push
Mar 28, 22:07
Stay Ahead of the Markets
Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.